In recent years, there has been a growing recognition of the effectiveness of innovative financing mechanisms in addressing funding shortfalls for market-driven solutions targeting social challenges. Such mechanisms can help battling antimicrobial resistance, which is an urgent and critical priority, especially ensuring rapid and precise diagnostics in underserved areas, writes healthcare veteran Dr Harsh Mahajan and IPE Global’s Ashwajit Singh.